Metformin versus Insulin for the Treatment of Gestational Diabetes
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking. METHODS: We randomly assigned 751 women with gestational diabetes mellitus at 20 to 33 weeks of gestation to open treatment with metformin (with supplemental insulin if required) or insulin. The primary outcome was a composite of neonatal hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-minute Apgar score less than 7, or prematurity. The trial was designed to rule out a 33% increase (from 30% to 40%) in this composite outcome in infants of women treated with metformin as compared with those treated with insulin. Secondary outcomes included neonatal anthropometric measurements, maternal glycemic control, maternal hypertensive complications, postpartum glucose tolerance, and acceptability of treatment. RESULTS: Of the 363 women assigned to metformin, 92.6% continued to receive metformin until delivery and 46.3% received supplemental insulin. The rate of the primary composite outcome was 32.0% in the group assigned to metformin and 32.2% in the insulin group (relative risk, 0.99 [corrected]; 95% confidence interval, 0.80 [corrected] to 1.23 [corrected]). More women in the metformin group than in the insulin group stated that they would choose to receive their assigned treatment again (76.6% vs. 27.2%, P<0.001). The rates of other secondary outcomes did not differ significantly between the groups. There were no serious adverse events associated with the use of metformin. CONCLUSIONS: In women with gestational diabetes mellitus, metformin (alone or with supplemental insulin) is not associated with increased perinatal complications as compared with insulin. The women preferred metformin to insulin treatment. (Australian New Zealand Clinical Trials Registry number, 12605000311651.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While individual RCTs support limited efficacy of metformin (73,74) and glyburide (75) in reducing glucose levels for the treatment of GDM, these agents are not recommended as the first-line treatment for GDM because they are known to cross the placenta and data on long-term safety for offspring is of some concern (35).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [73]
In the citing paper
“It was concluded that metformin alone, or with supplemental insulin, was not associated with increased perinatal complications.”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [112]
In the citing paper
“Blood glucose-lowering pharmacological therapy is effective at improving outcomes in women with gestational diabetes whose hyperglycemia does not respond sufficiently to lifestyle therapy (71, 82, 88–90).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [90]
In the citing paper
“Blood glucose-lowering pharmacological therapy is effective at improving outcomes in women with gestational diabetes whose hyperglycemia does not respond sufficiently to lifestyle therapy (71, 82, 88–90).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [89]
In the citing paper
“Glyburide is effective in controlling blood glucose in women with gestational diabetes”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [90]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Dabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes
Ben‐Haroush, A., Yogev, Y., & Hod, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00985.x · Cited by 856
Gestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677
Silverman, B. L., Metzger, B. E., Cho, N. H., & Loeb, C. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.611 · Cited by 643
Hoffman, L., Nolan, C., Wilson, J. D., Oats, J. J. N., & Simmons, D. (1998) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb140192.x · Cited by 570
An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000
Ferrara, A., Kahn, H. S., Quesenberry, C. P., Riley, C., & Hedderson, M. M. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000113623.18286.20 · Cited by 452
Glueck, C. J., Phillips, H., Cameron, D., Sieve-Smith, L., & Wang, P. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01666-6 · Cited by 430
Research works printed but not linked: 3
- Coetzee EJ, 1980, S Afr Med J, 58, 795
- Coetzee EJ, 1984, S Afr Med J, 65, 635
- Gutzin SJ, 2003, Can J Clin Pharmacol, 10, 179
Cited by
Items 301–400 of 1,001
Diagnosis and treatment of gestational diabetes
Webb, J. (2013) · Nurse Prescribing · doi:10.12968/npre.2013.11.1.14 · Cited by 33
Theranostic Advances of Bionanomaterials against Gestational Diabetes Mellitus: A Preliminary Review
Barani, M., Sargazi, S., Mohammadzadeh, V., Rahdar, A., Pandey, S., Jha, N. K., Gupta, P. K., & Thakur, V. K. (2021) · Journal of Functional Biomaterials · doi:10.3390/jfb12040054 · Cited by 34
“, insulin therapy and administration of metformin or glibenclamide), and postnatal managements present several therapeutic options associated with the enhanced glycemic control for both the mother and the child [8,13,14].”
BackgroundOgunyemi, D. A., Fong, A., Rad, S., Fong, S., & Kjos, S. L. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03326.x · Cited by 33
VANKY, E., DE ZEGHER, F., DÍAZ, M., IBÁÑEZ, L., & CARLSEN, S. M. (2012) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12015 · Cited by 32
“No difference was found in the prevalence of pre-eclampsia (15).”
BackgroundGestational Diabetes: An Update 60 Years After O’Sullivan and Mahan
McIntyre, H. D., Kampmann, U., Dalsgaard Clausen, T., Laurie, J., & Ma, R. C. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae709 · Cited by 32
Tan, M. H., Alquraini, H., Mizokami‐Stout, K., & MacEachern, M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.008 · Cited by 39
Bashir, M., Aboulfotouh, M. E., Dabbous, Z., Mokhtar, M. G., Siddique, M. A., Wahba, R. M., Ibrahim, A., Brich, S., Konje, J. C., & Abou‐Samra, A. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1550480 · Cited by 38
Haas, D. M., Gallauresi, B. A., Shields, K. E., Zeitlin, D., Clark, S. M., Hébert, M. F., Ren, Z., Nallani, S. C., Meslin, E. M., Feibus, K. B., et al. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00280.x · Cited by 33
Tertti, K., Ekblad, U., Heikkinen, T., Rahi, M., Rönnemaa, T., & Laine, K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.10.014 · Cited by 36
Approach to the Patient with Diabetes during Pregnancy
Hone, J., & Jovanovic, L. G. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0383 · Cited by 34
Optimizing weight for maternal and infant health: tenable, or too late?
Nicklas, J. M., & Barbour, L. A. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.991102 · Cited by 37
“3 kg in women randomized to insulin [114].”
BackgroundSafety Considerations with Pharmacological Treatment of Gestational Diabetes Mellitus
Simmons, D. S. (2014) · Drug Safety · doi:10.1007/s40264-014-0253-9 · Cited by 34
Pharmacological Management of Gestational Diabetes Mellitus
Mukerji, G., & Feig, D. S. (2017) · Drugs · doi:10.1007/s40265-017-0807-0 · Cited by 40
“after intensive lifestyle modification [53].”
BackgroundMetformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question
Tocci, V., Mirabelli, M., Salatino, A., Sicilia, L., Giuliano, S., Brunetti, F. S., CHIEFARI, E. D., Sarro, G. D., FOTI, D. P., & Brunetti, A. (2023) · Pharmaceuticals · doi:10.3390/ph16091318 · Cited by 39
“The largest RCT on this topic, the MIG trial, initially found a significantly higher rate of large for gestational age (LGA) births and preterm delivery in mothers treated with metformin (plus supplemental insulin if required) than in those treated with insulin for the management of GDM [109].”
BackgroundInfluentialComments on gestational diabetes mellitus: from pathophysiology to clinical practice
Poulakos, P., Mintziori, G., Tsirou, E., Taousani, E., Savvaki, D., Harizopoulou, V. C., & Goulis, D. G. (2015) · HORMONES · doi:10.14310/horm.2002.1570 · Cited by 41
Risk Factor Profile and Pregnancy Outcome in Women with Type 1 and Type 2 Diabetes Mellitus
Handisurya, A., Bancher‐Todesca, D., Schober, E., Klein, K., Tobler, K., Schneider, B. K., Pollak, A. J., Husslein, P. W., Luger, A., & Kautzky‐Willer, A. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2033 · Cited by 37
Cardiac function in gestational diabetes mellitus: A longitudinal study from fetal life to infancy
Aguilera, J., Semmler, J., Anzoategui, S., Zhang, H., Nicolaides, K. H., & Charakida, M. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16434 · Cited by 33
Odds ratio vs risk ratio in randomized controlled trials
Balasubramanian, H., Ananthan, A., Rao, S. C., & Patole, S. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1022494 · Cited by 34
“35) 1 0 [86] 63 Yusuf 2008 1423 8542 1412 8576 1.”
Oral Hypoglycemic Agents in pregnancy: An Update
Nagandla, K., De, S., & Kanagasabai, S. (2013) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-012-0312-z · Cited by 38
Update on Gestational Diabetes Mellitus
Evensen, A. E. (2011) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2011.11.011 · Cited by 40
Oral Agents for the Treatment of Gestational Diabetes
Finneran, M. M., & Landon, M. B. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1093-2 · Cited by 34
Elmaraezy, A., Faculty of Medicine, A.-A. U., Ibrahim Abushouk, A., Faculty of Medicine, A. S. U., Emara, A., Faculty of Medicine, A.-A. U., Elshahat, O., Faculty of Medicine, A.-A. U., Ahmed, H., Faculty of Medicine, Z. U., et al. (2017) · International Journal of Reproductive BioMedicine · doi:10.29252/ijrm.15.8.461 · Cited by 29
“Observational studies have also shown that metformin can significantly reduce maternal weight gain in women with gestational DM or polycystic ovarian syndrome (19, 20, 38).”
BackgroundSang, J., Dhakal, S., & Lee, Y. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.2245 · Cited by 30
“Moreover, this drug is also used to treat polycystic ovary syndrome and gestational diabetes (Rowan et al., 2008).”
Gatford, K. L., Houda, C. M., Lu, Z., Coat, S., Baghurst, P., Owens, J. A., Sikaris, K. A., Rowan, J., & Hague, W. M. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12080 · Cited by 32
“We have therefore compared maternal vitamin B12 stores (TB12), bioavailable vitamin B12 (HoloTC) and plasma Hcy concentrations, during and after pregnancy, in women with GDM treated with either insulin or metformin in samples collected during the metformin in gestational diabetes (MiG) trial [8].”
BackgroundMethodSelf-citationManoharan, V., & Wong, V. W. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03175-5 · Cited by 33
Coyne, L., & Stockdale, C. K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.036 · Cited by 29
Diabetes care and pregnancy outcomes for women with pregestational diabetes in Ireland
Newman, C., Egan, A. M., Ahern, T., Al-Kiyumi, M., Balan, G., Brassill, M. J., Brosnan, E., Carmody, L. A., Clarke, H., Kelly, C., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108685 · Cited by 34
Schoonejans, J. M., Blackmore, H. L., Ashmore, T. J., Pantaleão, L. C., Pisani, L. P., Dearden, L., Tadross, J. A., Aiken, C., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2022) · Diabetologia · doi:10.1007/s00125-022-05789-0 · Cited by 34
Tosti, G., Barberio, A., Tartaglione, L., Rizzi, A., Leo, M. A. S. D., Viti, L., Sirico, A., Carolis, S. D., Pontecorvi, A., Lanzone, A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1176623 · Cited by 36
“Rowan et al. led an offspring follow-up (TOFU) investigating the body composition at 2 years of age (62).”
BackgroundInfluentialManagement of type 2 diabetes in pregnancy: a narrative review
Raets, L., Ingelbrecht, A., & Benhalima, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193271 · Cited by 33
Therapeutic management of gestational diabetes
Jacqueminet, S., & Jannot-Lamotte, M.-F. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.016 · Cited by 34
Metformin treatment for Type 2 diabetes in pregnancy?
Simmons, D. S. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.05.002 · Cited by 32
Firneisz, G., Rosta, K., Al‐Aissa, Z., Hadarits, O., Harreiter, J., Nádasdi, Á., Bancher‐Todesca, D., Németh, L., Igaz, P., Rigó, J. J., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123734 · Cited by 30
“8% [32] to nearly half [33] of GDM patients who initiated their drug therapy with metformin eventually had to start AIT during pregnancy.”
BackgroundZhu, B., Zhang, L., Fan, Y., Wang, L., Li, X., Liu, T., Cao, Y., & Zhao, Z. (2016) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-016-1414-x · Cited by 28
“Nevertheless, only one RCT in our analysis had reported the ethnic groups studied but without report the result according to the race [8].”
Jung, C.-H., Jung, S.-H., Choi, D., Kim, B.-Y., Kim, C.-H., & Mok, J.-O. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108586 · Cited by 28
Herath, M. P., Beckett, J. M., Hills, A. P., Byrne, N. M., & Ahuja, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040835 · Cited by 31
“75% met the lower targets of the American Diabetes Association (5.3 and 6.7 mmol/L) 6 days ADP (Pea Pod) FM: Significantly higher (413 ± 192 vs. 350 ± 162, p = 0.003) %FM: Significantly higher (12.1 ± 4.3 vs. 10.1 ± 4.1, p = 0.003) Au, 2013 Cross-sectional September-October 2010 Royal Prince Alfred Hospital Sydney, Au…”
BackgroundMethodResultInfluentialPerea, V., Urquizu, X., Valverde, M., Macias, M., Carmona, A., Esteve, E., Escribano, G., Pons, N., Giménez, O., Gironés, T., et al. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0340 · Cited by 32
“In contrast to insulin [22], other antidiabetic medications such as metformin or glyburide are known to cross the placenta and have been associated with adverse neonatal outcomes such as preterm birth and neonatal hypoglycemia, respectively [23-25].”
Linder, T., Eder, A., Monod, C., Rosicky, I., Eppel, D., Redling, K., Geissler, F., Huhn, E. A., Hösli, I., & Göbl, C. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.799625 · Cited by 32
“001 Insulin BI total (IU/d) 12 (9-24) 12 (10-21) 16 (12-27) 0.”
BackgroundPrevalence, Trends, and Patterns of Use of Antidiabetic Medications Among Pregnant Women, 2001-2007
Lawrence, J. M., Andrade, S. E., Avalos, L. A., Beaton, S. J., Chiu, V. Y., Davis, R. L., Dublin, S., Pawloski, P. A., Raebel, M. A., Smith, D. H., et al. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318278ce86 · Cited by 32
“The Metformin in Gestational Diabetes Trial, published in 2008 after the deliveries in the present study, reported that metformin (alone or in combination with insulin) was not associated with increased perinatal complications and women reported preferring metformin to insulin treatment.(23) Based on previous studies,…”
ResultManagement of gestational diabetes mellitus
Lapolla, A., Fedele, & Dalfra (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s3407 · Cited by 41
Tieu, J., Coat, S., Hague, W. M., Middleton, P., & Shepherd, E. S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007724.pub3 · Cited by 37
Self-citationPregnancy outcome after first-trimester exposure to metformin: A prospective cohort study
Scherneck, S., Schlinke, N., Beck, E., Grupe, K., Weber-Schoendorfer, C., & Schaefer, C. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.07.004 · Cited by 28
Barrett, H. L., Dekker Nitert, M., Jones, L., O’Rourke, P., Lust, K., Gatford, K. L., De Blasio, M. J., Coat, S., Owens, J. A., Hague, W. M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2132 · Cited by 28
Self-citationConway, D. (2012) · Wiley eBooks · doi:10.1002/9781119963783.ch20 · Cited by 28
Unresolved controversies in gestational diabetes: implications on maternal and infant health
Barbour, L. A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000080 · Cited by 26
“The largest experience with metformin has been in GDM women later in pregnancy from the metformin in gestation (MiG) trial [35] in which 751 women with GDM were randomized to metformin versus insulin after exclusion of hypertension and fetal growth restriction.”
Impact of Metformin Treatment on Human Placental Energy Production and Oxidative Stress
Tarry‐Adkins, J. L., Robinson, I. G., Reynolds, R. M., Aye, I. L. M. H., Charnock‐Jones, D. S., Jenkins, B., Koulmann, A., Ozanne, S. E., & Aiken, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.935403 · Cited by 36
“Metformin is relatively inexpensive and welltolerated (Rowan et al., 2008), and thus suitable for use globally, including in low-resource settings.”
BackgroundThe Hirsute Woman: Challenges in Evaluation and Management
Paparodis, R. D., & Dunaif, A. E. (2011) · Endocrine Practice · doi:10.4158/ep11117.ra · Cited by 27
Metformin-Loaded Hyaluronic Acid Nanostructure for Oral Delivery
Bhujbal, S. V., & Dash, A. K. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1085-1 · Cited by 28
Glucose Lowering Treatment Modalities of Type 2 Diabetes Mellitus
Canpolat, A. G., & Şahin, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_516 · Cited by 29
Efficacy of metformin versus insulin in the management of pregnancy with diabetes.
Waheed, S., Malik, F. P., & Mazhar, S. B. (2013) · PubMed · Cited by 30
Gestational Diabetes — Setting Limits, Exploring Treatments
Ecker, J. L., & Greene, M. F. (2008) · New England Journal of Medicine · doi:10.1056/nejme0802623 · Cited by 29
Dainelli, L., Prieto Patron, A., Silva-Zolezzi, I., Sosa Rubi, S. G., Espino y Sosa, S., Reyes Muñoz, E., Lopez-Ridaura, R., & Detzel, P. (2018) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s160658 · Cited by 26
“49 The observed high proportion of doctors indicating women to take OHA in Mexico could be related to their lower price compared with insulin or to the preference for this type of treatment.”
Denney, J. M., & Quinn, K. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2018.01.003 · Cited by 34
“Pharmacologic studies demonstrate that metformin freely crosses the placenta, rendering a circulating fetal concentration roughly 50% that found in maternal circulation.(48) Accordingly, a landmark trial published by Rowan and colleagues(49) called the Metformin in Gestational Diabetes (MIG) trial compared the outcome…”
BackgroundResultInfluentialVillota, S. D., Toledo‐Rodriguez, M., & Leach, L. (2020) · Diabetologia · doi:10.1007/s00125-020-05290-6 · Cited by 26
Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention
Thakkar, A., Hailu, T., Blumenthal, R. S., Martin, S. S., Harrington, C. M., Yeh, D. D., French, K. A., & Sharma, G. V. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01026-6 · Cited by 28
Gestationsdiabetes mellitus (GDM)
Kleinwechter, H. J., Schäfer-Graf, U. M., Bührer, C., Hoesli, I. M., Kainer, F., Kautzky‐Willer, A., Pawlowski, B., Schunck, K., SOMVILLE, T., & Sorger, M. (2011) · Diabetologie und Stoffwechsel · doi:10.1055/s-0031-1283757 · Cited by 28
Rojas, J., Chávez-Castillo, M., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/797681 · Cited by 28
“This research group ascertained metformin (500– 2500mg/day) with or without supplemental insulin not to be associated with higher perinatal complications, in comparison to insulin alone [157], findings later corroborated by Silva et al.”
ResultGuzmán‐Gutiérrez, E., Abarzua, F., Belmar, C., Nien, J. K., Ramírez, M. A., Arroyo, P., Salomón, C., Westermeier, F., Puebla, C., Leiva, A., et al. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111797484062 · Cited by 28
Hughes, R. C. E., Rowan, J., & Williman, J. A. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-018493 · Cited by 28
Self-citationObesity and abnormal glucose tolerance in the offspring of mothers with diabetes
Kawasaki, M., Arata, N., & Ogawa, Y. (2018) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000479 · Cited by 28
Optimal management of gestational diabetes
Egan, A. M., & Dunne, F. (2019) · British Medical Bulletin · doi:10.1093/bmb/ldz025 · Cited by 29
Metformin in gestational diabetes: An emerging contender
Singh, A. K., & Singh, R. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.149317 · Cited by 31
“[17] The results clearly suggested, no significant increase in composite measures of neonatal complications in metformin treated mother.”
Kautzky‐Willer, A., Harreiter, J., Bancher‐Todesca, D., Berger, A., Repa, A., Lechleitner, M., & Weitgasser, R. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0941-1 · Cited by 34
Diagnosis and Treatment of Hyperglycemia in Pregnancy
Mohan, S., & Egan, A. M. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.05.011 · Cited by 41
Gregg, B. E., Botezatu, N., Brill, J. D., Hafner, H., Vadrevu, S., Satin, L. S., Alejandro, E. U., & Bernal‐Mizrachi, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-23965-4 · Cited by 25
Sciacca, L., Bianchi, C., Burlina, S., Formoso, G., Manicardi, E., Sculli, M. A., & Resi, V. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02137-5 · Cited by 33
“Maternal hypertensive complications and postpartum glucose tolerance did not differ between the two groups [55].”
BackgroundInfluentialKautzky‐Willer, A., Bancher‐Todesca, D., Pollak, A. J., Repa, A., Lechleitner, M., & Weitgasser, R. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0265-3 · Cited by 31
Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery
Panidis, D., Τζιόμαλος, Κ., Papadakis, E. P., & Katsikis, I. (2012) · Frontiers of hormone research · doi:10.1159/000341824 · Cited by 28
Pellonperä, O., Rönnemaa, T., Ekblad, U., Vahlberg, T. J., & Tertti, K. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12788 · Cited by 27
Maternal Gestational Diabetes and Fetal Congenital Heart Disease: An Observational Study
Hunter, L. E. (2015) · Journal of Pregnancy and Child Health · doi:10.4172/2376-127x.1000132 · Cited by 25
The use of oral antidiabetic medications in gestational diabetes mellitus
Paglia, M. J., & Coustan, D. R. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0044-3 · Cited by 27
Diagnosis, prevention and management of gestational diabetes mellitus
Wang, C., & Yang, H. (2016) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2016.11.004 · Cited by 31
“glyburide, metformin, and insulin had the same ability to control the fasting and postprandial blood glucose levels of women with GDM, and no significant differences in the incidence rates of adverse maternal and neonatal outcomes were found among them.(26,27) However, a recent RCT showed that the failure rates of met…”
ResultBrawerman, G. M., & Dolinsky, V. W. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.002 · Cited by 33
Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical Trial
Rademaker, D., de Wit, L., Duijnhoven, R. G., Voormolen, D. N., Mol, B. W., Franx, A., DeVries, J. H., Painter, R. C., van Rijn, B. B., SUGAR-DIP Study Group, et al. (2025) · JAMA · doi:10.1001/jama.2024.23410 · Cited by 25
Brand, K. M. G., Gottwald‐Hostalek, U., & Andag‐Silva, A. (2025) · Women s Health · doi:10.1177/17455057241311759 · Cited by 38
“99 The incidence of the primary composite foetal/neonatal outcome was 32% in each group.”
Predictors of metformin failure in gestational diabetes mellitus (GDM)
Khin, M. O., Gates, S., & Saravanan, P. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.01.003 · Cited by 24
Venkatesh, K. K., Chiang, C., Castillo, W. C., Battarbee, A., Donneyong, M. M., Harper, L. M., Costantine, M. M., Saade, G. A., Werner, E., Boggess, K., et al. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16960 · Cited by 29
Mazhar, D., Haq, N. U., Zeeshan, M., Ain, Q., Ali, H., Khan, S., & Khan, S. A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104448 · Cited by 24
Exposure of mouse embryonic pancreas to metformin enhances the number of pancreatic progenitors
Gregg, B. E., Elghazi, L., Alejandro, E. U., Smith, M. R., Blandino-Rosano, M., El‐Gabri, D., CRAS-MÉNEUR, C. M. H., & Bernal‐Mizrachi, E. (2014) · Diabetologia · doi:10.1007/s00125-014-3379-5 · Cited by 25
“Metformin is being studied for use during pregnancy in polycystic ovary syndrome and gestational diabetes [24, 25].”
BackgroundTreating diabetes during pregnancy
Klein, J., Charach, R., & Sheiner, E. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.988140 · Cited by 27
“The study results indicated that metformin is not associated with increased risk of adverse perinatal outcomes when compared to insulin [59].”
BackgroundXu, Q., & Xie, Q. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05124-w · Cited by 29
D’Ambrosio, V., Brunelli, R., Vena, F., Mascio, D. D., Marchetti, C., Boccherini, C., Piccioni, M. G., Panici, P. B., & Giancotti, A. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3164 · Cited by 25
“Additionally, in the Metformin in Gestational Diabetes (MiG) study, children of women randomized to the metformin group had lower visceral body fat at 2 years than those ofwomenwho took insulin, even if there was not enough evidence to confirm these results.(30) Conversely, as metformin crosses the placenta, the long‐…”
ResultCao, Q., Hu, Y., Fu, J., Huang, X., Wu, L., Zhang, J., & Huang, W. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15044 · Cited by 26
“In two earlier meta-analyses and a recent RCT study, metformin increased preterm delivery versus insulin in women with GDM.(23,32,33) However, since these studies were performed in women with GDM, it is of limited significance to us, especially when animal experiments and mechanism studies have initially confirmed the…”
ResultInfluentialDiabetes: how to manage gestational diabetes mellitus
Mukherjee, S. M., & Dawson, A. (2022) · Drugs in Context · doi:10.7573/dic.2021-9-12 · Cited by 33
Role of metformin in the management of type 2 diabetes: recent advances
Gonzalez-Lopez, C., & Wojeck, B. S. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16511 · Cited by 28
Placental dysfunction in obese women and antenatal surveillance strategies
Jeve, Y. B., Konje, J. C., & Doshani, A. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.09.007 · Cited by 30
Utz, B., Kolsteren, P. W., & Brouwere, V. D. (2015) · Clinical Diabetes · doi:10.2337/diaclin.33.3.152 · Cited by 24
“Metformin is not yet recommended as an oral alternative for insulin despite its proven comparability (27,28).”
BackgroundForcato, S., Novi, D. R. B. S., Costa, N. O., Borges, L. I., de Góes, M. L. M., Ceravolo, G. S., & Gerardin, D. C. C. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.08.023 · Cited by 25
Mechanisms and Clinical Significance of Endothelial Dysfunction in High-Risk Pregnancies
McLaughlin, K., Audette, M. C., Parker, J. D., & Kingdom, J. C. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.01.006 · Cited by 23
Pharmacological treatment of gestational diabetes mellitus: point/counterpoint
Langer, O. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.01.024 · Cited by 27
Management of Type 2 Diabetes and Gestational Diabetes in Pregnancy
Boinpally, T., & Jovanovič, L. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20115 · Cited by 30
Ha, V., Bonner, A., Jadoo, J. K., Beyene, J., Anand, S. S., & de Souza, R. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182095 · Cited by 26
Tratamento farmacológico do diabetes na gestação
Zajdenverg, L., Dualib, P. M., Lauand, T. C. G., Reichelt, A. J., Satler, F., Façanha, C. F. S., Golbert, A., Negrato, C. A., Araújo, C. A. R., & Bertoluci, M. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-13 · Cited by 51
Metformin derivatives – Researchers’ friends or foes?
Torunoglu, S. T., Zajda, A., Tampio, J., Markowicz-Piasecka, M., & Huttunen, K. M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115743 · Cited by 23
Dodd, J. M. (2014) · Annals of Nutrition and Metabolism · doi:10.1159/000365018 · Cited by 24
Contemporary management of gestational diabetes
Lee-Parritz, A. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32834cd3c4 · Cited by 23
Role of Metformin in the Treatment of Gestational Diabetes
Wensel, T. M. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l562 · Cited by 24
Soriano, L. C., García‐Rodríguez, L. A., Brodovicz, K. G., Massó-González, E. L., Bartels, D. B., & Hernández–Díaz, S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13275 · Cited by 24
Benziv, R. G., & Hod, M. (2008) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539508002234 · Cited by 30
Gobello, C., Baschar, H. A., Castex, G., de la Sota, R. L., & Goya, R. G. (2001) · PubMed · Cited by 24
Metadata
- Authors
- Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P.
- Affiliations
- Auckland City Hospital (NZ)
- Women's and Children's Hospital (AU)
- Auckland University of Technology (NZ)
- University of Auckland (NZ)
- Christchurch Hospital (NZ)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-05-08
- Volume
- 358
- Issue
- 19
- Pages
- 2003-2015
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2003621575
- Cited by
- 1,291
- References
- 33
- Citations by year
- 2026: 49 · 2025: 60 · 2024: 52 · 2023: 65 · 2022: 63 · 2021: 90 · 2020: 67 · 2019: 66 · 2018: 105 · 2017: 125 · 2016: 68 · 2015: 82 · 2014: 69 · 2013: 62 · 2012: 56
- FWCI
- 78.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, insulin, gestational diabetes mellitus, neonatal hypoglycemia, perinatal complications, maternal glycemic control, postpartum glucose tolerance, treatment acceptability, treatment preferences, neonatal respiratory distress, phototherapy
- MeSH terms
- Adult, Drug Therapy, Combination, Female, Gestational Age, Humans, Hypoglycemia, Hypoglycemic Agents, Infant, Newborn, Insulin, Jaundice, Neonatal, Metformin, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Outcome, Diabetes, Gestational, Patient Satisfaction, Premature Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.